Ablation of FAS confers allogeneic CD3- CAR T cells with resistance to rejection by T cells and natural killer cells.
Menegatti S, Lopez-Cobo S, Sutra Del Galy A, Fuentealba J, Silva L, Perrin L, Heurtebise-Chrétien S, Pottez-Jouatte V, Darbois A, Burgdorf N, Privat AL, Simon A, Laprie-Sentenac M, Saitakis M, Wick B, Webber BR, Moriarity BS, Lantz O, Amigorena S, Menger L.
Menegatti S, et al.
Nat Biomed Eng. 2024 Nov 18. doi: 10.1038/s41551-024-01282-8. Online ahead of print.
Nat Biomed Eng. 2024.
PMID: 39558141